Shaheen NJ, Adler J, Dedrie S et al. Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy. Aliment Pharmacol Ther. 2015;41:649–661.

[pdf-embedder url=”https://iwgco.net/wp-content/uploads/securepdfs/2021/12/Shaheen-APT-2015.pdf” title=”Shaheen APT 2015″]

IWGCO Email Support

Please contact us if you are having trouble using an IWGCO educati0nal program.  We will do our best to respond promptly to your email, but please keep in mind that IWGCO is a voluntary organization.